Metabolism and Presynaptic Inhibitory Activity of 2',3' and 5'-adenine Nucleotides in Rat Vas Deferens

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 1981 Sep 1

PMID 7300914

Citations 6

Authors

J WILLEMOT

D M Paton

Affiliations

Soon will be listed here.

Abstract

In the isolated rat vas deferens stimulated at 0.2 Hz, [14C]labelled 5'-AMP, 5'-ADP and 5'-ATP (10 microM) inhibited twitch responses, were broken down to [14C]adenosine in the medium and incorporated into [14C]adenine ribonucleotides in the tissue. Pretreatment of tissues with 6-(2-hydroxy-5-nitrobenzyl)-thioguanosine (NBTGR), a potent inhibitor of adenosine transport, potentiated the presynaptic inhibitory action of these 5' nucleotides and reduced their incorporation in [14C]adenine nucleotides, but did not alter the appearance of [14C]adenosine in the medium. A series of 2', 3' and 5'-substituted adenine nucleotides (10 microM) inhibited the twitch responses of the vas deferens stimulated at 0.2 Hz. This effect was potentiated by NBTGR. Addition of exogenous adenosine deaminase very significantly reduced the inhibitory actions of adenosine, 5'-AMP, 5'-ADP and 5'-ATP and also reduced those of 2', 5'-ADP, NAD+ and dePCoA. The inhibitory actions of the other 2', 3' and 5' adenine nucleotides studied were not altered by exogenous adenosine deaminase. These results indicated that the presynaptic inhibitory actions of 5'-AMP, 5'-ADP and 5'-ATP in rat vas deferens predominantly result from their prior hydrolysis to adenosine whereas the 2', 3' and 5'-substituted adenine nucleotides appear to act mainly directly to inhibit transmitter release.

Citing Articles

The 2',3'-cAMP-adenosine pathway.

Jackson E Am J Physiol Renal Physiol. 2011; 301(6):F1160-7.

PMID: 21937608 PMC: 3233866. DOI: 10.1152/ajprenal.00450.2011.

Proceedings of the British Pharmacological Society. University of Dundee, 11th-14th September, 1984. Abstracts.

Br J Pharmacol. 1984; 83 Suppl:349P-463P.

PMID: 6509265 PMC: 1986970.

Indirect evidence that purinergic modulation of perivascular adrenergic neurotransmission in the portal vein is a physiological process.

Burnstock G, Crowe R, Kennedy C, Torok J Br J Pharmacol. 1984; 82(2):359-68.

PMID: 6329393 PMC: 1987025. DOI: 10.1111/j.1476-5381.1984.tb10770.x.

Purine receptors in the rat anococcygeus muscle.

Stone T J Physiol. 1983; 335:591-608.

PMID: 6308222 PMC: 1197372. DOI: 10.1113/jphysiol.1983.sp014553.

Amphetamine-clonidine interaction on neurotransmission in the vas deferens of the rat.

Fiszman M, STEFANO F Naunyn Schmiedebergs Arch Pharmacol. 1984; 328(2):148-53.

PMID: 6098834 DOI: 10.1007/BF00512064.

References

Wakade A, Wakade T . Inhibition of noradrenaline release by adenosine. J Physiol. 1978; 282:35-49. PMC: 1282722. DOI: 10.1113/jphysiol.1978.sp012446. View

Chaudry I, Baue A . Further evidence for ATP uptake by rat tissues. Biochim Biophys Acta. 1980; 628(3):336-42. DOI: 10.1016/0304-4165(80)90383-9. View

Hopkins S . The action of ATP in the guinea-pig heart. Biochem Pharmacol. 1973; 22(3):335-9. DOI: 10.1016/0006-2952(73)90414-0. View

Frick G, Lowenstein J . Vectorial production of adenosine by 5'-nucleotidase in the perfused rat heart. J Biol Chem. 1978; 253(4):1240-4. View

Clanachan A, Johns A, Paton D . Presynaptic inhibitory actions of adenine nucleotides and adenosine on neurotransmission in the rat vas deferens. Neuroscience. 1977; 2(4):597-602. DOI: 10.1016/0306-4522(77)90056-2. View

Cass C, Paterson A . Nitrobenzylthionionosine binding sites in the erythrocyte membrane. Biochim Biophys Acta. 1976; 419(2):285-94. DOI: 10.1016/0005-2736(76)90354-0. View

Burger R, Lowenstein J . 5'-Nucleotidase from smooth muscle of small intestine and from brain. Inhibition of nucleotides. Biochemistry. 1975; 14(11):2362-6. DOI: 10.1021/bi00682a014. View

Baer H, DRUMMOND G . Catabolism of adenine nucleotides by the isolated perfused rat heart. Proc Soc Exp Biol Med. 1968; 127(1):33-6. DOI: 10.3181/00379727-127-32614. View

Eilam Y, Cabantchik Z . Nucleoside transport in mammalian cell membranes: a specific inhibitory mechanism of high affinity probes. J Cell Physiol. 1977; 92(2):185-201. DOI: 10.1002/jcp.1040920207. View

10.

MANERY J, Riordan J, DRYDEN E . Characteristics of nucleotide-converting enzymes at muscle surfaces with special reference to ion sensitivity. Can J Physiol Pharmacol. 1968; 46(3):537-47. DOI: 10.1139/y68-078. View

11.

Muller M, Paton D . Presynaptic inhibitory actions of 2-substituted adenosine derivatives on neurotransmission in rat vas deferens: effects of inhibitors of adenosine uptake and deamination. Naunyn Schmiedebergs Arch Pharmacol. 1979; 306(1):23-8. DOI: 10.1007/BF00515589. View

12.

WILLEMOT J, Paton D . Metabolism and presynaptic inhibitory effects of adenosine in rat vas deferens. J Auton Pharmacol. 1981; 1(3):217-24. DOI: 10.1111/j.1474-8673.1981.tb00450.x. View

13.

Fleit H, Conklyn M, Stebbins R, Silber R . Function of 5'-nucleotidase in the uptake of adenosine from AMP by human lymphocytes. J Biol Chem. 1975; 250(23):8889-92. View

14.

Crabtree G, HENDERSON J . Rate-limiting steps in the interconversion of purine ribonucleotides in Ehrlich ascites tumor cells in vitro. Cancer Res. 1971; 31(7):985-91. View

15.

Bruns R, Daly J, Snyder S . Adenosine receptors in brain membranes: binding of N6-cyclohexyl[3H]adenosine and 1,3-diethyl-8-[3H]phenylxanthine. Proc Natl Acad Sci U S A. 1980; 77(9):5547-51. PMC: 350099. DOI: 10.1073/pnas.77.9.5547. View

16.

Paton D . Presynaptic inhibition of neurotransmission in rat vas deferens by 2-(p-methoxyphenyl) adenosine, ethyl adenosine-5'-carboxylate and N-cyclopropyl adenosine-5'-carboxamide. J Pharm Pharmacol. 1980; 32(2):133-5. DOI: 10.1111/j.2042-7158.1980.tb12869.x. View

17.

Eilam Y, Carbantchik I . The mechanism of interaction between high-affinity probes and the uridine transport system of mammalian cells. J Cell Physiol. 1976; 89(4):831-8. DOI: 10.1002/jcp.1040890451. View